1 stock to buy now for the ‘worst cold ever’

Reckitt Benckiser has posted an excellent Q3 trading update as demand for its cold and flu medicines soars. Charles Archer thinks it could be an attractive addition to his portfolio right now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

If, like me, you’re feeling under the weather, it might be comforting to know that you’re not alone. After nearly two years of limited social mixing, most restrictions are now lifted. Workers are commuting, face mask mandates are over, and family visits are back on. But the natural consequence is a resurgence of cold and flu viruses. And unfortunately it seems they’re back with a vengeance. However, there’s always a silver lining. For me, it’s this stock I’d buy now.

Reckitt Benckiser (LSE: RKT) has just posted much better-than-expected results, as demand for its brands, including Nurofen and Strepsils, has soared. In fact, its OTC (over-the-counter) “portfolio grew over 20% in the quarter, driven primarily by Mucinex sales, which benefited from a sharp improvement in cold and flu sales trends”. 

Q3 results

Driven by high OTC demand, like-for-like sales rose 3.3% to over £3bn, while analyst consensus was an expected 0.7% drop. And full-year net revenue growth guidance is now up to between 1% and 3% year-on-year, compared to a Q2 estimate of between 0% and 2%. Encouragingly, the company has maintained its guidance on profit margins in the face of high inflation. But growth is expected to be slower than in 2020, when the global demand for cleaning products like its disinfectant brand Dettol saw revenue rise 12%.

However, with pubs, bars and nightclubs now all fully open, sales of its market leading Durex condoms brand also rose. The company said that “strong growth in intimate wellness continued, up mid-single-digits”. And as autumn turns to winter, the temptation of a warm pub surrounded by friends means punters will be more likely to need Reckitt Benckiser’s cold and flu remedies as well. 

A stock to buy now?

At 5,946p, the Reckitt Benckiser share price is up 6% in just five days. But it’s down 13% from 6,852p earlier this year. And with a five-year average of 6,551p, I think there’s significant upside potential for the stock. But it’s worth noting that its dividend yield for the past three years has been around 2.8%. And the FTSE 100 average is predicted to be around 4.1% in 2021. Therefore, it needs to see significant share price growth to beat the index return (and inflation).

And of course, Reckitt Benckiser has the same pressures as the rest of the FTSE 100. In its Q3 report, it warned that raw materials had increased in price by 10% over the quarter. And if it wants to maintain the same profit margins, then the prices it charges will have to rise. CEO Laxman Narasimhan has said that “there will be another round of pricing we will take to offset the inflation”. And with a cost of living crisis currently escalating, some consumers may not feel able to justify spending significantly more on branded products. 

But I think Reckitt Benckiser has such a large portfolio of widely used brands, that I’m confident it will be able to build on its latest performance. And I’m fairly sure that sales are going to rise in the short term. For me, it’s a stock to buy now. And my colleague, Christopher Ruane, agrees with me.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Charles Archer has no position in any of the shares mentioned. The Motley Fool UK has recommended Reckitt plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

This dividend stock’s yielding 5.5% but its directors have sold nearly 15m shares this month!

Our writer takes a closer look at an AIM-listed dividend stock. But despite its impressive yield, some of its directors…

Read more »

Woman using laptop and working from home
Investing Articles

Should PayPal be on my list of shares to buy?

Is a 9% free cash flow yield from a growing business with a strong balance sheet enough to get a…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

1 bit of Warren Buffett advice I’m ignoring

Warren Buffett's take on buying individual shares may surprise some people. But there's a logic to it. What's our writer's…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

£20,000 in savings? Here’s how it could be used to target passive income of £913 each month

Christopher Ruane illustrates the explosive passive income potential of buying dividend shares, using a £20k lump sum as an example.

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

3 growth stocks I’ve bought for the ‘AI agent’ revolution

Edward Sheldon sees AI agents as one of the most exciting themes in the stock market. Here are three growth…

Read more »

ISA Individual Savings Account
Investing Articles

Putting these 4 in a Stocks and Shares ISA gives exposure to over 1,000 companies at a 10.6% discount!

With increased global uncertainty on the rise, our writer thinks it’s a good time for anyone with a Stocks and…

Read more »

UK supporters with flag
Investing Articles

8.5% dividend yield! Should investors consider buying this high-income FTSE stock today?

This FTSE renewable energy giant's fallen out of fashion, but it now offers one of the highest sustainable dividend yields…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

Is this penny stock on track for an explosive recovery in 2025?

This penny stock could almost triple its earnings by 2026 if it successfully executes a turnaround strategy, potentially sending its…

Read more »